OXYCURE
Board
2 directors, 1 auditorHARDY CHANTAL
Director
since 29-03-2023
term until 28-03-2029
listed in the 2025 annual accounts, filed on 29-01-2026
THOMAS FRANCIS
Director
since 29-03-2023
term until 28-03-2029
listed in the 2025 annual accounts, filed on 29-01-2026
Statutory auditor
since 20-06-2024
term until 31-01-2027
listed in the 2025 annual accounts, filed on 29-01-2026
Mandates through the years
4 names, the dashed line is todayHARDY CHANTAL
Director
Director
THOMAS FRANCIS
Director
Director
DGST & PARTNERS - Réviseurs d'entreprises SRL
Statutory auditor
Statutory auditor
J-M DEREMINCE
Statutory auditor
Statutory auditor
BoardRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- HARDY CHANTAL
- Director, since before 30-06-2022
- THOMAS FRANCIS
- Director, since before 30-06-2022
- DGST & PARTNERS - Réviseurs d'entreprises SRL
- Statutory auditor, from 20-06-2024 to date
- J-M DEREMINCE
- Statutory auditor, appointed by deed of 08-04-2022, no longer listed in the 2025 annual accounts
Control
Shareholder
CHANTAL HARDY
50%
This company
OXYCURE
Equity €2.4m
Profit €17,778 in 2025
Capital
- Capital
- €997,800
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- CHANTAL HARDY
- FRANCIS THOMAS
Source: shareholder structure in its own accounts
Shareholders
2 ownersOwners 2
- CHANTAL HARDYnatural personSourceown accounts 30-06-202550%
- FRANCIS THOMASnatural personSourceown accounts 30-06-202550%